article thumbnail

Maine and Nevada Update Drug Price Transparency Laws

FDA Law

Schlanger — Maine and Nevada previously enacted laws requiring drug manufacturers to report information about the pricing of their products. Both states’ new requirements will become effective in October 2021 and should be considered as manufacturers prepare for state drug price transparency reporting in 2022.

article thumbnail

Green Practice News: May 2025

My Green Doctor

The product manufacturers and vendors will need to be active partners as well. From rising asthma rates to heat-related illnesses, climate change is already harming the most vulnerable among us. Visit our website to explore membership options, start a Practice Management program, or speak with us about our Consulting Services.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ninth Circuit Upholds FDA’s Authority to Regulate Stem Cell Clinic Treatments

FDA Law

These procedures are offered to treat a variety of conditions, including Alzheimer’s, arthritis, asthma, cancer, etc., Court Opinion One of Defendant’s primary arguments was that its SVF treatments constituted the practice of medicine, not the manufacture and administration of a “drug” and were, therefore, not subject to FDA regulation.

Clinic 59
article thumbnail

An Arm and a Leg: The Prescription Drug Playbook, Part I

Physician's Weekly

In January of last year, Cole went to a Walgreens in Appleton, Wisconsin, to get refills on the medication he used to control his asthma. A few days later, he had a massive asthma attack. A few days later, he had a massive asthma attack. He’d been taking it for years, and he expected to pay about seventy bucks.